Concepedia

Biljana Blagojevic

BB

Statistics

Publications

5

Citations

168

H-Index

5

Active since

2018

Affiliations

Heidelberg University(Current)

University Hospital Heidelberg

Biljana Blagojevic is an author at Heidelberg University specializing in cell signaling, medicine, and transcriptional regulation.

Top concepts

Publications per year

2018–2021

5

Publications

5

Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance

Zeribe C. Nwosu, Weronika Piorońska, Nadia Battello et al. · EBioMedicine · 2020 · 60 citations · Full text

A Ruthenium(II) N-Heterocyclic Carbene (NHC) Complex with Naphthalimide Ligand Triggers Apoptosis in Colorectal Cancer Cells via Activating the ROS-p38 MAPK Pathway

Yasamin Dabiri, Alice Kristin Schmid, Jannick Theobald et al. · International Journal of Molecular Sciences · 2018 · 36 citations · Full text

Pharmacological activation of pyruvate kinase M2 reprograms glycolysis leading to TXNIP depletion and AMPK activation in breast cancer cells

Fadi Almouhanna, Biljana Blagojevic, Suzan Can et al. · Cancer & Metabolism · 2021 · 35 citations · Full text

pVHL-mediated SMAD3 degradation suppresses TGF-β signaling

Jun Zhou, Yasamin Dabiri, Rodrigo A. Gama-Brambila et al. · The Journal of Cell Biology · 2021 · 19 citations · Full text

, , +18

Activation of pro-survival metabolic networks by 1,25(OH)2D3 does not hamper the sensitivity of breast cancer cells to chemotherapeutics

Mohamed A. Abu el Maaty, Yasamin Dabiri, Fadi Almouhanna et al. · Cancer & Metabolism · 2018 · 18 citations · Full text

1–5 of 5